| Bioactivity | Zastaprazan is a proton pump inhibitor (WO2018008929). Zastaprazan can be used for the research of gastrointestinal inflammatory diseases or gastric acid-related diseases[1]. | ||||||||||||
| Target | proton pump | ||||||||||||
| Invitro | Zastaprazan is a proton pump inhibitor[1] | ||||||||||||
| Name | Zastaprazan | ||||||||||||
| CAS | 2133852-18-1 | ||||||||||||
| Formula | C22H26N4O | ||||||||||||
| Molar Mass | 362.47 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO2018008929 |